Dr. Hendricks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6410 Rockledge Dr
Ste 506
Bethesda, MD 20817Phone+1 301-897-1503Fax+1 301-581-0254
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1988 - 1991- Johns Hopkins UniversityResidency, Internal Medicine, 1985 - 1988
- Johns Hopkins University School of MedicineClass of 1985
Certifications & Licensure
MD State Medical License 1988 - 2026
NJ State Medical License 2014 - 2015- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow of the American Society of Clinical Oncology American Society of Clinical Oncology, 2018
- Top Doctors:Washington DC Area Castle Connolly, 2012
- Top Doctors:Baltimore Area Castle Connolly, 2012
- Join now to see all
Clinical Trials
- Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab Start of enrollment: 2010 Mar 01
- A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
- Join now to see all
Publications & Presentations
PubMed
- 298 citationsPhase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor.Eric K. Rowinsky, Louise B. Grochow, Carolyn B. Hendricks, David S. Ettinger, Arlene A. Forastiere
Journal of Clinical Oncology. 1992-04-01 - 28 citationsIdentification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locusChenjie Zeng, Xingyi Guo, Jirong Long, Karoline Kuchenbaecker, Arnaud Droit
Breast Cancer Research. 2016-06-21 - 49 citationsDouble-blind phase III trial of adjuvant chemotherapy withand without bevacizumab in patients with lymph node-positiveand high-risk lymph node-negative breast cancer (...Kathy D. Miller, Anne O'Neill, William J. Gradishar, Timothy J. Hobday, Lori J. Goldstein
Journal of Clinical Oncology. 2018-07-24
Press Mentions
Shop TalkJanuary 5th, 2021- Carolyn Hendricks, MD, FASCO, Named ASCO Advocate of the YearSeptember 16th, 2020
Federal Funding Is Critical to Continuing Progress Against Cancer, ASCO Tells CongressOctober 30th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
